Mer

Home / WEST NILE-INNOVATOR®

WEST NILE-INNOVATOR®

DEMONSTRATED EFFICACY WITH LIVING PROOF

WEST NILE-INNOVATOR vaccines deliver demonstrated protection against West Nile Virus (WNV). WEST NILE-INNOVATOR vaccines aid in the prevention of viremia caused by WNV; equine encephalomyelitis due to Eastern, Western and Venezuelan viruses; and tetanus.

Efficacy of the West Nile fraction was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with WNV. The vaccine protected 95% of the vaccinates against infection, while 82% of the controls were viremic.

WEST NILE-INNOVATOR is veterinarian’s first choice for equine WNV protection.¹

IMPORTANT NOTICE!

Please note that this is a general product information according to US approvals, for specific regulatory information concerning your market please contact Regulatory department email: Regulatory.AffairsMER@zoetis.com

Close

Expand All
  • Key Benefits

    Demonstrated Efficacy

      • WEST NILE-INNOVATOR vaccine was shown to be 96.7% effective against a 2003 outbreak among immunologically naïve horses.²

      • The vaccine credited for helping reduce the number of equine WNV cases by nearly 70 percent from 2002 to 2003³

        Advanced Technology

      • The only WNV vaccine adjuvanted with MetaStim® for improved immune response

      • Helps stimulate fast, antigen-specific, cell-mediated and humoral response against WNV4

         

  • Dosing And Adminstration

    Convenient Combinations

      • The Mosquito ShotTM (WEST NILE-INNOVATOR +EWT) helps protect against WNV, eastern equine encephalomyelitis, western equine encephalomyelitis and tetanus in one convenient vaccine

      • Four combinations to fit any vaccination protocol

      • Ready-to-use; no reconstitution required

      • Inject 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 or 6 weeks after the first dose in unvaccinated or naïve horses. A 1 mL revaccination should be given annually in previously vaccinated horses. Always read and follow label indications

      • Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make exposure likely

  • Cautions

    Store in the dark at 2o to 7oC (35o to 45oF). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. Thimerosal, neomycin and polymyxin B are added as preservatives. For veterinary use only.